- Market Capitalization, $K 32,320,776
- Shares Outstanding, K 160,656
- Annual Sales, $ 2,155 M
- Annual Income, $ 487,710 K
- 60-Month Beta 0.91
- Price/Sales 15.17
- Price/Cash Flow 69.01
- Price/Book 7.85
|Period||Period Low||Period High||Performance|
| || |
-14.57 (-6.73%)since 09/01/23
| || |
+5.56 (+2.83%)since 07/03/23
| || |
+35.29 (+21.17%)since 10/03/22
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LEO Pharma, a global leader in medical dermatology, is using Veeva Vault Safety to optimize its...
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that palleos healthcare has selected Veeva Vault Clinical Data Management Suite (CDMS) with Veeva...
Reflecting On Vertical Software Stocks’ Q2 Earnings: Veeva Systems (NYSE:VEEV)
Both companies have trounced the market over the past five years.
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, is...
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault Batch Release, a new cloud application that will enable faster, more confident GMP...
Which of these cloud-based CRM leaders is the better buy?
Small and large dividend stock and ETF investors can use covered calls and puts trades to generate monthly income from options premiums and options trading.
This niche cloud software company's growth is accelerating again.
|Veeva Systems Inc|
|Nasdaq Lux Digital Health Solutions ETF|
|US Healthcare Providers Ishares ETF|
|Vaneck Morningstar Wide Moat ETF|
|DJ Internet Index ETF FT|
|Ark Genomic Revolution ETF|
|3rd Resistance Point||206.10|
|2nd Resistance Point||204.41|
|1st Resistance Point||202.79|
|1st Support Level||199.48|
|2nd Support Level||197.79|
|3rd Support Level||196.17|